Cite

HARVARD Citation

    Kronsten, V. et al. (2021). A 'real‐world' retrospective multi‐centre cohort study comparing infliximab and adalimumab for the maintenance of remission in ulcerative colitis. GastroHep. 3 (4), pp. 229-235. [Online]. 
  
Back to record